The page is the record's research on the issuer — no analyst, no rating, no view. # Bausch Health Companies Inc. (NYSE: BHC) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Bausch Health Companies Inc., listed on the NYSE under ticker BHC. Its ISIN is US0717341079. Its LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-NJ). Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, New Jersey. Its segment is not on the record. Its status is listed, not halted. ## The disclosure read The record holds 67 filings in the twelve months to 2026-11-08, across 36 filing days. The median gap between filing days is 6 days. The latest filing is dated 2026-10-29 and is of type results, 10 days before the record date. The NYSE median is 6.0 days of cadence gap, 64.0 filings and 4.0 days of latency across 3256 issuers. The 2834 Pharmaceutical Preparations sector median is 6.0 days of cadence gap, 63.0 filings and 4.0 days of latency across 526 issuers. The filings by type are: 38 directors' dealings, 9 results, 8 regulatory filings, 7 corporate news, 3 AGM/EGM and 2 director changes. ## Auditor The auditor of record is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). Its location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change events. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's own investor-relations page names 6 research houses: Barclays, Evercore ISI, Jefferies, Raymond James, RBC Capital Markets and TD Cowen. ## Open research No openly published research notes were found. The record holds none. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The vintage is sealed. The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0000885590.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/BHC (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.ir.bauschhealth.com/stock-information/analyst-coverage (coverage) - https://mcp.us-cm-kg.ai/record/NYSE/BHC (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/BHC · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp